If you look at Yamamoto's research on this.
It makes alot of sense.
When your own body's healthy cells grow in the wrong place, which is cancer.
eg: a toenail cell growing in the middle of your brain.
The body's normal reaction is to attack it and kill it because it knows its in the wrong place.
But what these cells do before they announce themselves as what kind of cell they are.
Is turn off this communication process.
The immune system thinks this is just a normal brain cell but its not, its mutated into a toenail cell.
But the immune system now can not tell this.
This yamamoto process is turning it back on.
Its like a communication stream between cells and the damaged cells turn this off.
This process of course does exist or human life would be mutated all over the place.
It is not dissimilar to a virus in a computer, which gets in as a harmless file or packet, turns "off" the anti virus, then creates itself as the actual harmful virus and starts growing, and there is nothing you can do about it because the fighting processes have been disabled.
People might have many damaged cells, that turn into the wrong kind of cell during there lifetime.
And the body's macrophage process kills them.
The problem is there is no way to make much money from this.
Yamamoto has patented the process, and has made nothing so far.
Because its just not attractive to investors because its quick and cheap.
This needs to be available for people to try.
When you are at deaths door you should be able to try everything and anything.
I cant believe this isn't available to people.Even if no one can make money from it.It should be available.

Originally posted by coven
Nice to read this two months after my uncle just died from prostate cancer...

This not being in the public eye the day it was announced is disgusting...

I agree

Nice to read this 8 years after my dad died of pancreatic cancer.

This is a very crucial information. Bumping this thread up.

The subtle difference here is that this treatment has been "Peer Reviewed".

This Japanese researcher, Nobuto Yamamoto, has published several peer reviewed studies and articles involving GcMAF(also called Vitamin D3-Binding Protein-Derived Macrophage Activating Factor).

This is exactly like DCA, another downplayed treatment.

In spite of being peer reviewed, this has been ignored by the mainstream oncology establishment.

I will bump this up also; the problem is, there is no money for all those blood sucking weasels at the pharma corps and the researchers in providing a cheap effective cure for cancer; take lots of vitamin d and pass the word to everyone; money is the root of all evil and they would rather have everyone suffer and die just so they can make a buck off of it.

WAKE UP,PEOPLE!!!!

seeker